లంగ్ క్యాన్సర్ (నాన్-స్మాల్ సెల్)

The purpose of this study is to understand if PF-08046054 alone works well compared to standard-of-care docetaxel alone in participants with non-small cell lung cancer (NSCLC) with PD-L1 expression greater than or equal to 1% and had cancer progression during or after treatment with PD-L1 or PD-1 inhibitors, platinum-based chemotherapy, and targeted treatment regimen(s) for participants with known actionable genomic alterations (AGAs). Participants in this study must have cancer that has spread through their body or can't be removed with surgery or treated with definitive radiation. Participa…

స్పాన్సర్: ఫైజర్
ClinicalTrials.gov లో NCT07144280
రిజిస్ట్రీలో చివరిసారిగా 13 Oct 2026 న అప్‌డేట్ చేయబడింది · మేము 20 Oct 2026 న చదివాము